As on Wednesday, ATAI Life Sciences N.V (NASDAQ: ATAI) started slowly as it slid -8.09% to $1.59, before settling in for the price of $1.73 at the close. Taking a more long-term approach, ATAI posted a 52-week range of $1.02-$2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -16.02% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 44.19%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -217.14%. This publicly-traded company’s shares outstanding now amounts to $166.03 million, simultaneously with a float of $117.06 million. The organization now has a market capitalization sitting at $266.81 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2350, while the 200-day Moving Average is $1.5572.
ATAI Life Sciences N.V (ATAI) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. ATAI Life Sciences N.V’s current insider ownership accounts for 30.24%, in contrast to 7.20% institutional ownership. According to the most recent insider trade that took place on Sep 26 ’24, this organization’s 10% Owner sold 2,660,000 shares at the rate of 6.05, making the entire transaction reach 16,093,000 in total value, affecting insider ownership by 6,905,774. Preceding that transaction, on May 16 ’24, Company’s insider sold 151,303 for 1.92, making the whole transaction’s value amount to 290,502. This particular insider is now the holder of 328,697 in total.
ATAI Life Sciences N.V (ATAI) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
ATAI Life Sciences N.V’s EPS decrease for this current 12-month fiscal period is -217.14% and is forecasted to reach -0.62 in the upcoming year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Let’s observe the current performance indicators for ATAI Life Sciences N.V (ATAI). It’s Quick Ratio in the last reported quarter now stands at 5.81. The Stock has managed to achieve an average true range (ATR) of 0.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 808.51.
In the same vein, ATAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.80, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.62 at the market close of one year from today.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Through scrutinizing the latest numbers posted by the [ATAI Life Sciences N.V, ATAI], it can be observed that its last 5-days Average volume of 4.07 million was better the volume of 1.21 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 61.90% While, its Average True Range was 0.2120.
Raw Stochastic average of ATAI Life Sciences N.V (ATAI) in the period of the previous 100 days is set at 60.87%, which indicates a major rise in contrast to 60.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 116.88% that was higher than 74.88% volatility it exhibited in the past 100-days period.
